Advertisement

Topics

Alfa Chemicals Ltd Company Profile

18:01 EDT 24th September 2018 | BioPortfolio

Alfa Chemicals Ltd. is one of the leading distributors of speciality chemicals throughout the UK & Ireland. Since its formation in 1976, we have remained independent and stuck closely to our fundamental premise of working in partnership with our Principals & Customers.

We are particularly strong in the following markets: Pharmaceutical, Personal Care, Nutraceutical, Plastics & Polyurethanes, Coatings & Inks, Cleaners & Polishes, Metal Working & Finishing. A range of services are offered that ensures Customers receive the level of care which industry requires & expects.

Location

Arc HouseTerrace Road South
Binfield
Bracknell
RG42 4PZ
United Kingdom

Contact

Phone: 01344 861 800
Fax: 01344 451 400
Email: info@alfa-chemicals.co.uk


News Articles [466 Associated News Articles listed on BioPortfolio]

FDA Approves Retacrit (epoetin alfa-epbx) as First Epoetin Alfa Biosimilar for the Treatment of Anemia

May 15, 2018 -- The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney ...

Pfizer: FDA Oks First Epoetin Alfa Biosimilar For Treatment Of Anemia

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced the United States Food and Drug Administration approved Retacrit orepoetin alfa-epbx, a biosimilar to Epogen and Procrit (epoetin alfa), for a...

FDA Approves Pfizer’s Retacrit, the First Epoetin Alfa Biosimilar for the Treatment of Anemia

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) approved RETACRIT® (epoetin alfa-epbx), a biosimilar to Epogen...

FDA approves Pfizer’s epoetin alfa biosimilar Retacrit

FDA Approves Epoetin Alfa Biosimilar for Anemia

The FDA has approved epoetin alfa-epbx (Retacrit) as a biosimilar to epoetin alfa (Epogen/Procrit) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in p...

Human medicines European public assessment report (EPAR): Pergoveris, follitropin alfa / lutropin alfa, Revision: 12, Authorised

FDA approves Pfizer’s epoetin alfa biosimilar Retacrit to treat anemia

Pfizer’s Retacrit (epoetin alfa-epbx), a biosimilar to Amgen’s anemia drug Epogen/Procrit (epoetin alfa), has been approved by the US Food and Drug Administration (FDA) for all indications of the ...

Pending EC decision: Epoetin Alfa Hexal, epoetin alfa, Opinion date: 26-Jul-2018

Drugs and Medications [108 Associated Drugs and Medications listed on BioPortfolio]

Ribavirin [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets Initial U.S. Approval: 200...

Sundrops 67 [Sunburst Chemicals, Inc.]

SunDrops 67

Sofskin baby [Nova Petroleum & Chemicals Corporation]

Baby Oil

Sofskin baby [Nova Petroleum & Chemicals Corporation]

Baby Petroleum Jelly

Sundrops 73 [Sunburst Chemicals, Inc.]

SunDrops 73

PubMed Articles [324 Associated PubMed Articles listed on BioPortfolio]

Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (RetacritTM) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis.

For patients with anemia undergoing hemodialysis, erythropoiesis-stimulating agents (ESAs) are typically dosed via precise algorithms. Using one such algorithm, we assessed the maintenance of hemoglob...

Correction to: Andexanet Alfa: First Global Approval.

The article Andexanet Alfa: First Global Approval, written by Young-A Heo, was originally published Online First without open access.

An easy-to-use baseline scoring system to predict response to peginterferon alfa-2a in patients with chronic hepatitis B in resource-limited settings.

Approximately one-third of patients have durable responses after finite (48-week) treatment with peginterferon alfa-2a. The ability to identify patients likely to respond would be particularly useful ...

Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: the history of a success.

: The development of alloantibodies against the replacement of Factor VIII (FVIII) is the major complication in haemophilia A treatment. The gold standard to eradicate inhibitors is the immune toleran...

Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model.

Increasing use of factor Xa (FXa) inhibitors necessitates effective reversal agents to manage bleeding. Andexanet alfa, a novel modified recombinant human FXa, rapidly reverses the anticoagulation eff...

Clinical Trials [1129 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Reduction and Viral Safety of IFN Alfa-2b XL + Ribavirin Versus PEG IFN Alfa-2b + Ribavirin in Patients With Chronic Hepatitis C Genotype 1

The purpose of this study is to confirm if IFN alfa-2b XL has a better antiviral activity and tolerability as compared with current marketed reference, while combined with ribavirin, in a ...

Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

The purpose of this study is to evaluate the cost-effectiveness of epoetin alfa compared with darbepoetin alfa in the treatment of anemia in adults receiving chemotherapy for cancer. Epoe...

PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients

The purpose of this study is to demonstrate that once every-2-weeks and once every-4-weeks treatment with epoetin alfa, a drug that increases red blood cell production, in patients with an...

Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders

In an opened randomized study of women undergoing in vitro fertilization with expected suboptimal response to controlled ovarian stimulation (Poseidon Group 2b) investigators will examine ...

Breath Test for Chemicals (Volatile Organic Compounds)

Background: - Some types of cancer, like cancer of the esophagus, are difficult to detect at an early stage. A possible detection method involves collecting breath samples to look for che...

Companies [587 Associated Companies listed on BioPortfolio]

Alfa Chemicals Ltd

Alfa Chemicals Ltd. is one of the leading distributors of speciality chemicals throughout the UK & Ireland. Since its formation in 1976, we have remained independent and stuck closely to our fundament...

Alfa Laval

Alfa Laval is a leading global provider of specialized products and engineered solutions. Our equipment, systems and services are dedicated to helping customers to optimize the performance of their pr...

Alfa Scientific Designs, Inc.

Alfa Scientific Designs, Inc. is a leader in the development and manufacture of rapid, immunoassay, point-of-care tests. As a minority, woman-owned, small business, ALFA offers a ...

Assisted Living Federation of America (ALFA)

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors an...

Assisted Living Federation of America

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors and families they serve...

More Information about "Alfa Chemicals Ltd" on BioPortfolio

We have published hundreds of Alfa Chemicals Ltd news stories on BioPortfolio along with dozens of Alfa Chemicals Ltd Clinical Trials and PubMed Articles about Alfa Chemicals Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alfa Chemicals Ltd Companies in our database. You can also find out about relevant Alfa Chemicals Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record